NanoGroup S.A. Logo

NanoGroup S.A.

Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.

NNG | WAR

Overview

Corporate Details

ISIN(s):
PLNNGRP00011 (+3 more)
LEI:
259400HXWEAZUWRLY648
Country:
Poland
Address:
Warszawa Rakowiecka 36, 02-532 Warszawa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NanoGroup S.A. is a biotechnology company that develops and commercializes innovative medical solutions based on its unique, patented nanotechnology. The group's research and development work is concentrated on addressing critical medical needs, primarily in the fields of oncology and transplantology. Key projects include the development of nanoformulations for anticancer drugs, a fluid for the storage of organs intended for transplantation, nanoparticles for diagnostics and therapy, and a human blood substitute. The company operates through specialized subsidiaries, such as nanoSanguis and nanoVelos, to advance its distinct technological platforms and bring new medical technologies to market.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-08 16:18
Regulatory News Service
Oświadczenie
Polish 156.9 KB
2025-10-08 16:18
Regulatory News Service
Oświadczenie
Polish 131.2 KB
2025-10-08 16:18
Regulatory News Service
Powołanie osób nadzorujących - członków Rady Nadzorczej drugiej kadencji - Cont…
Polish 1.3 KB
2025-10-08 16:04
Regulatory News Service
Rezygnacja Członka Rady Nadzorczej - Content (PL)
Polish 508 bytes
2025-10-08 15:53
Regulatory News Service
Lista akcjonariuszy
Polish 51.0 KB
2025-10-08 15:53
Regulatory News Service
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajnym…
Polish 378 bytes
2025-10-08 15:37
Regulatory News Service
Treść uchwał
Polish 127.5 KB
2025-10-08 15:37
Regulatory News Service
Treść uchwał podjętych podczas obrad Nadzwyczajnego Walnego Zgromadzenia NanoGr…
Polish 1010 bytes
2025-10-06 16:58
Board/Management Information
Oświadczenie
Polish 156.9 KB
2025-10-06 16:58
Board/Management Information
Życiorys
Polish 324.7 KB
2025-10-06 16:58
Board/Management Information
Zgłoszenie kandydata na Członka Rady Nadzorczej NANOGROUP S.A. - Content (PL)
Polish 766 bytes
2025-10-06 12:47
Board/Management Information
Oświadczenie
Polish 131.2 KB
2025-10-06 12:47
Board/Management Information
Życiorys
English 199.3 KB
2025-10-06 12:47
Board/Management Information
Zgłoszenie kandydata na Członka Rady Nadzorczej NANOGROUP S.A. - Content (PL)
Polish 780 bytes
2025-10-01 17:02
Related Party Transaction
Powiadomienie
Polish 4.4 KB

Automate Your Workflow. Get a real-time feed of all NanoGroup S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NanoGroup S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Psych Capital Plc Logo
A life sciences firm developing psilocybin treatments for anorexia and mental health conditions.
United Kingdom PSY
Pure Biologics S.A. Logo
Develops novel antibody & aptamer drugs for immuno-oncology and autoimmune diseases.
Poland PUR
Puretech Health PLC Logo
A clinical-stage biotherapeutics company developing new medicines for devastating diseases.
United States of America PRTC
PZ Cormay S.A. Logo
Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.
Poland CRM
Quantum Genomics Logo
Biopharma developing cardiovascular treatments, now in judicial liquidation.
France ALQGC
Quratis Inc. Logo
Develops infectious disease vaccines and offers biologics CDMO services for global health.
South Korea 348080
Recordati Industria Chimica e Farmaceutica Logo
Global pharma group developing drugs for common/rare diseases & supplying APIs worldwide.
Italy REC
Rekah Pharmaceutical Prod Ltd. Logo
A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.
Israel REKA
Replek AD Logo
Manufactures & distributes generic medicines, supplements, and cosmetic products to over 25 countries.
North Macedonia REPL
Respiratorius AB Logo
Develops oncology pre-treatment drugs to enhance the efficacy of standard cancer therapies.
Sweden RESP

Talk to a Data Expert

Have a question? We'll get back to you promptly.